Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Pearson

Showing results (81-90 of 225) with videos related to

Pageof 23
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
21-day schedule oral etoposide in children--a feasibility studyA Davidson, I Lewis, A D Pearson, et al.
Lancet (London, England)|July 15, 1989
Nephrotoxicity of ifosfamide in childrenR Skinner, A D Pearson, L Price, et al.
Lancet (London, England)|June 13, 1992
Enterococcal superinfection in paediatric oncology patients treated with imipenemJ W Gray, S Pedler, J Kernahan, et al.
Biochemical Pharmacology|February 25, 2000
Camptothecin-stabilised topoisomerase I-DNA complexes in leukaemia cells visualised and quantified in situ by the TARDIS assay (trapped in agarose DNA immunostaining)K Padget, R Carr, A D Pearson, et al.
Cancer Research|February 24, 2001
Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell lineD A Tweddle, A J Malcolm, N Bown, et al.
Genes, Chromosomes & Cancer|July 1, 1997
Promiscuous translocations of chromosome arm 17q in human neuroblastomasM Lastowska, P Roberts, A D Pearson, et al.
Archives of Disease in Childhood|July 1, 1990
Nephrotoxicity after ifosfamideR Skinner, A D Pearson, L Price, et al.
British Medical Journal|October 8, 1977
Campylobacter-associated diarrhoea in SouthamptonA D Pearson, W G Suckling, I D Ricciardi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Phase I trials in pediatric oncology: perceptions of pediatricians from the United Kingdom Children's Cancer Study Group and the Pediatric Oncology GroupE J Estlin, S Cotterill, C B Pratt, et al.
British Journal of Cancer|October 1, 1993
p53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosisE Jaros, J Lunec, R H Perry, et al.
Pageof 23

Showing results (81-90 of 225) with videos related to

Sort By:
Pageof 23
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
21-day schedule oral etoposide in children--a feasibility studyA Davidson, I Lewis, A D Pearson, et al.
Lancet (London, England)|July 15, 1989
Nephrotoxicity of ifosfamide in childrenR Skinner, A D Pearson, L Price, et al.
Lancet (London, England)|June 13, 1992
Enterococcal superinfection in paediatric oncology patients treated with imipenemJ W Gray, S Pedler, J Kernahan, et al.
Biochemical Pharmacology|February 25, 2000
Camptothecin-stabilised topoisomerase I-DNA complexes in leukaemia cells visualised and quantified in situ by the TARDIS assay (trapped in agarose DNA immunostaining)K Padget, R Carr, A D Pearson, et al.
Cancer Research|February 24, 2001
Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell lineD A Tweddle, A J Malcolm, N Bown, et al.
Genes, Chromosomes & Cancer|July 1, 1997
Promiscuous translocations of chromosome arm 17q in human neuroblastomasM Lastowska, P Roberts, A D Pearson, et al.
Archives of Disease in Childhood|July 1, 1990
Nephrotoxicity after ifosfamideR Skinner, A D Pearson, L Price, et al.
British Medical Journal|October 8, 1977
Campylobacter-associated diarrhoea in SouthamptonA D Pearson, W G Suckling, I D Ricciardi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Phase I trials in pediatric oncology: perceptions of pediatricians from the United Kingdom Children's Cancer Study Group and the Pediatric Oncology GroupE J Estlin, S Cotterill, C B Pratt, et al.
British Journal of Cancer|October 1, 1993
p53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosisE Jaros, J Lunec, R H Perry, et al.
Pageof 23